Koyfin Home > Directory > Health Care > Intellia Thera CS > Cash from Financing Activities

Intellia Thera CS Cash from Financing Activities Chart (NTLA)

Intellia Thera CS annual/quarterly Cash from Financing Activities from 2014 to 2020.
  • Intellia Thera CS Cash from Financing Activities for the quarter ending June 06, 2020 was $132m a 64.91% increase of 86m year over year
  • Intellia Thera CS Cash from Financing Activities for the last 12 months ending June 06, 2020 was $203m a 57.14% increase of 116m year over year
  • Intellia Thera CS Annual Cash from Financing Activities for 2019 was $76m a 47.38% increase of 36m from 2018
  • Intellia Thera CS Annual Cash from Financing Activities for 2018 was $40m a -255.52% decrease of -103m from 2017
  • Intellia Thera CS Annual Cash from Financing Activities for 2017 was $143m a -17.01% decrease of -24m from 2016
Other Cash Flow Metrics:
  • Intellia Thera CS Cash Flow from Operations for the quarter ending September 09, 2018 was $-12m a -71.08% increase of 9m year over year
  • Intellia Thera CS Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-4m a -189.64% increase of 8m year over year
  • Intellia Thera CS Total Revenue for the quarter ending September 09, 2018 was $7m a 9.99% increase of 1m year over year
View Chart On Koyfin

Quarterly NTLA Cash from Financing Activities Data

06/2020$132m
03/2020$5m
12/2019$20m
09/2019$46m
06/2019$6m
03/2019$4m
12/2018$30m
09/2018$2m
06/2018$1m
03/2018$7m

Annual NTLA Cash from Financing Activities Data

2019$76m
2018$40m
2017$143m
2016$167m
2015$70m
2014$19m